USE OF MIRASOL® PATHOGEN REDUCTION TECHNOLOGY (PRT) TO PREVENT CMV TRANSMISSION IN A MOUSE TRANSFUSION MODEL

被引：0
|
作者：
Roback, D. [1 ]
Newman, L. [1 ]
Saakadze, N. [1 ]
Keil, D. [2 ]
Goodrich, P. [2 ]
机构：
[1] Emory Univ, Sch Med, Atlanta, GA USA
[2] LLC, CaridianBCT Biotechnol, Lakewood, CO USA
来源：
VOX SANGUINIS | 2010年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：256 / 256
页数：1
相关论文
共 50 条
  • [1] THE EFFECT OF MIRASOL PATHOGEN REDUCTION TREATMENT (PRT) ON THE FUNCTION OF PLATELET CONCENTRATE TRANSFUSION PRODUCTS
    Zeddies, S.
    van der Meer, P. F.
    de Cuyper, I. M.
    Gerrits, A. J.
    Daal, B.
    de Korte, D.
    Thijssen-Timmer, D. C.
    Gutierrez, L.
    [J]. VOX SANGUINIS, 2013, 105 : 54 - 54
  • [2] Prevention of alloimmunization to platelets and cardiac transplants by mirasol, pathogen reduction technology (PRT).
    Asano, Hiroshi
    Lee, Chih-Yuan
    Baldwin, William M.
    Marschner, Susanne
    Goodrich, Raymond
    [J]. BLOOD, 2006, 108 (11) : 282A - 282A
  • [3] Photochemical inactivation of Chikungunya virus using the Mirasol® pathogen reduction technology (PRT) system
    Keil, S.
    Vanlandingham, D.
    Tsetsarkin, K.
    Goodrich, R.
    Higgs, S.
    [J]. TRANSFUSION, 2008, 48 (02) : 89A - 89A
  • [4] Effects of a new pathogen-reduction technology (Mirasol PRT) on platelet function.
    Diaz-Ricart, M
    Perez-Pujol, S
    Tonda, R
    Lozano, M
    Fuste, B
    Lopez-Vilchez, I
    Galan, AM
    Li, JZ
    Goodrich, R
    Escolar, G
    [J]. BLOOD, 2004, 104 (11) : 988A - 988A
  • [5] Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates
    Perez-Pujol, S
    Tonda, R
    Lozano, M
    Fuste, B
    Lopez-Vilchez, I
    Galan, AM
    Li, J
    Goodrich, R
    Escolar, G
    [J]. TRANSFUSION, 2005, 45 (06) : 911 - 919
  • [6] PHOTOCHEMICAL INACTIVATION OF USUTU VIRUS USING THE MIRASOL PATHOGEN REDUCTION TECHNOLOGY (PRT) SYSTEM FOR PLATELETS
    Rossini, G.
    Silenzi, S.
    Govoni, M.
    Randi, V
    Pierro, A. M.
    Gaibani, P.
    Cavrini, F.
    Landini, M. P.
    Sambri, V
    [J]. VOX SANGUINIS, 2012, 103 : 188 - 188
  • [7] Molecular and cell biological evaluations of human WBC inactivation using Mirasol® pathogen reduction technology (PRT)
    Li, J
    McLean, R
    Goodrich, RP
    [J]. TRANSFUSION, 2005, 45 (03) : 29A - 29A
  • [8] MIRASOL PATHOGEN REDUCTION TECHNOLOGY (PRT) TREATMENT OF P. YOELII CONTAMINATED PLASMA NEUTRALIZES PARASITE IN A MURINE MODEL FOR MALARIA
    Kiser, P.
    Keil, S.
    Marschner, S.
    Avery, A.
    [J]. VOX SANGUINIS, 2012, 103 : 136 - 136
  • [9] The Mirasol Evaluation Program:: Use of Mirasol Pathogen Reduction Technology for platelets in routine clinical practice
    Cock, P. D.
    Vaquero, M.
    Garcia, R.
    Marceno, R.
    Fusco, G. D.
    Freitas, A.
    Goodrich, R.
    [J]. TRANSFUSION, 2008, 48 (02) : 156A - 156A
  • [10] Neutrophil Priming Activity in Platelet Concentrates (PCs) Collected by Apheresis and Treated with Mirasol® Pathogen Reduction Technology (PRT)
    Ambruso, D. R.
    Thurman, G.
    Tran, K.
    Marschner, S.
    Goodrich, R. P.
    [J]. TRANSFUSION, 2009, 49 : 9A - 9A
12345